Your body is always checking its own cells for signs of trouble. The immune system can recognize and destroy many abnormal cells before they ever become cancer. This built-in defense is called immune surveillance. Specialized cells patrol the body, spot the unusual proteins cancer cells make and move in to kill them.
The immune system fights cancer in three stages. It recognizes abnormal cells by the unusual proteins they make, attacks them with specialized cells like natural killer cells and T cells, and adapts when tumors try to escape.
Short Version
The immune system fights cancer through immune surveillance. Cells such as natural killer cells, T cells and macrophages detect abnormal proteins on cancer cells and destroy them. Some tumors evade this defense by hiding their markers or switching off immune cells, which is what immunotherapy aims to reverse.
How Does the Immune System Recognize a Cancer Cell?
The immune system spots cancer by reading the proteins on a cell’s surface. Healthy cells display normal markers. Cancer cells often make unusual proteins called tumor antigens, which act like a warning sign that something is wrong.
Immune surveillance
The constant patrol in which immune cells scan the body for cells that look or behave abnormally.
Tumor antigens
Unusual proteins on a cancer cell’s surface that flag it as no longer normal.
Antigen presentation
When one immune cell breaks down these markers and shows them to other immune cells so they know to respond.
Spotting the warning sign starts with antigen presentation. Chemical messengers called cytokines, such as interleukin-7, then tell immune cells when to grow and where to go. This signaling lets the immune system organize an attack on the right targets.
Some proteins are far more common in cancer cells than in healthy ones, which gives the immune system and researchers a way to spot the disease. One is a protein-folding helper called CCT. Cancer cells use CCT to build the proteins they need to survive and spread, which makes it a useful marker. A growth signal called FGFR4 can point to abnormal growth as well. This work comes from Professor Annette Khaled, who leads the 麻豆原创 Division of Cancer Research.
We鈥檝e found that all cancer cells share something in common, a protein-folding complex. With this insight we developed a drug that we鈥檙e partnering with the Orlando VA Healthcare System, thanks to the generous support of Orlando Sports Foundation and Alan Gooch 鈥�84 鈥�89MA, to test with patient specimens.”
Which Immune Cells Attack Cancer Cells?
The body uses several types of immune cells to find and kill cancer, and each one plays a different role.
Natural killer cells
Natural killer cells are the body’s first line of defense. When one locks onto a cancer cell, it punches tiny holes in the cell wall using a protein called perforin. It then sends in enzymes that make the cancer cell self-destruct. Research from the Alicja Copik Lab at 麻豆原创 has shown these cells can be boosted with nanoparticles to multiply and kill more effectively.
Macrophages
Macrophages swallow and break down tumor cells, a process called phagocytosis. Using time-lapse microscopy, scientists have watched them consume cancer cells on contact. They work with dendritic cells, which call in more immune cells to keep the response going.
Cytotoxic T cells
Cytotoxic T cells lead coordinated attacks, but only when they have enough energy to keep fighting. Work at the Burnett School of Biomedical Sciences shows they rely on internal energy-management pathways known as AKT and mTOR. These keep the cells fit inside the harsh environment of a tumor.
Why Can Cancer Escape the Immune System?
Cancer often finds ways to dodge the immune system. One trick is to shut the immune response down. Many tumors display a molecule called PD-L1 on their surface, which tells approaching immune cells to stand down and stop the attack.
The space around a tumor, called the tumor microenvironment, makes the job even harder. It often lacks oxygen or carries signals that weaken immune cells. Work at the Altomare Lab suggests that the growth signal FGFR4 not only helps cancer grow but may also block immune cells from working. Tumors also contain many different kinds of cancer cells, so the immune system rarely catches all of them.
Cancer can also hide. Through a process called antigen loss, cells that mutate to cover up their warning markers survive and multiply. Some tumors lean on molecular brakes such as TIGIT. Highly active immune cells tend to carry a lot of TIGIT. Certain experimental treatments aimed at this brake can backfire by making immune cells attack each other. This problem, called fratricide, weakens the body’s overall defense.
How Does Immunotherapy Build on the Immune System?
Immunotherapy works by strengthening or reprogramming the immune system rather than relying only on outside chemicals. Checkpoint inhibitors are a leading example. These drugs use antibodies to block signals like PD-L1, which frees immune cells to attack again.
Other treatments change the immune cells themselves. In cell-based therapies such as CAR-T or modified natural killer cell therapy, scientists engineer immune cells to work better. Research from the Alicja Copik Lab uses nanotechnology to stimulate natural killer cells, delivering chemical messengers that make them multiply quickly. These cells can be engineered to remove brakes like TIGIT so they stay fit enough to keep killing cancer. Because the stimulated cells do not attack healthy tissue, they can be donated from one person to another with a low risk of rejection.
Nanoparticles and cancer vaccines support these treatments by carrying signaling molecules straight to immune cells. This boosts both their numbers and their ability to kill tumors, without traditional chemotherapy. In 麻豆原创 lab studies, stimulated cells cleared tumors within days. Pairing them with checkpoint inhibitors improved survival in early animal studies, partly by prompting the tumor to show the very markers the drugs are designed to find.
How Do Scientists Study the Immune System’s Fight Against Cancer?
Scientists study the immune system’s fight against cancer in three main ways: by finding biomarkers, by watching immune cells in action and by studying how age changes the response.
Biomarkers are measurable signs, usually specific proteins, that show how a cancer is behaving and how the immune system is reacting. 麻豆原创 researchers found that high levels of the CCT protein complex point to cancer that is more advanced and more likely to spread, which makes it a useful biomarker.
Researchers also study how immune cells and tumors interact one cell at a time. A team at the Burnett School of Biomedical Sciences built CancerCellTracker, a free, open-source tool. It reads time-lapse microscopy images to follow thousands of cells at once and record the moment an immune cell kills a cancer cell. Paired with machine-learning tools like TLCellClassifier, it lets scientists watch these battles unfold and count exactly when cancer cells die.
Age also shapes how the immune system fights cancer. 麻豆原创 researchers study especially aggressive cancers, such as triple negative breast cancer. They use proteomics, the large-scale study of the body’s proteins, along with mass spectrometry to find biomarkers tied to age. The goal is to map a tumor’s immune landscape and turn tumors that hide from the immune system into targets it can attack, which points toward more personalized treatment.
Summary: How the Body Defends Itself Against Cancer
- Immune surveillance is the body’s built-in patrol. Specialized cells scan for tumor antigens, the unusual proteins cancer cells make. 麻豆原创 Cancer Division Head Khaled’s team found that high levels of the CCT protein complex help mark a cell as cancerous.
- Natural killer cells are a main attacker. They bind to abnormal cells, punch holes in them with perforin and deliver enzymes that trigger programmed cell death.
- Macrophages swallow and break down cancer cells through phagocytosis, working with dendritic cells that call in reinforcements.
- Tumors fight back. Many display PD-L1 to switch off immune cells, and immunotherapy uses antibodies to block that signal so the attack can resume.
- Nanoparticles can supercharge the body’s defense by delivering chemical messengers that make immune cells multiply. These cells can be engineered to remove brakes like TIGIT so they keep killing cancer.
- Defenses have limits. A tumor’s harsh surroundings can starve immune cells of oxygen, and some treatments can backfire by causing immune cells to attack each other, a problem called fratricide.
- Fighting cancer is a constant cycle of detection, activation and destruction. Its success comes down to whether immune cells stay fit enough to outlast a tumor’s evolving escape tricks.
Frequently Asked Questions About How the Immune System Fights Cancer
Nanoparticles deliver chemical messengers straight to immune cells to switch them on and help them grow. This offers a chemotherapy-free way to increase the number of tumor-killing cells without the side effects of radiation or chemical drugs. Some nanoparticle treatments also push tumors to display the markers that immunotherapy drugs are designed to target.
The immune system spots cancer by detecting unusual proteins called tumor antigens on a cell’s surface. Immune cells process these markers and show them to the rest of the immune system to trigger a response. 麻豆原创 research has found that protein complexes such as CCT are far more common in cancer cells, which helps mark them as a threat.
Natural killer cells are a first line of defense. They bind to cancer cells, punch holes in them with a protein called perforin and deliver enzymes that cause programmed cell death. In the lab, these cells can be stimulated with nanoparticles to multiply up to 10,000-fold and kill more effectively.
Tracking immune cells is hard because microscope images can be low-resolution and cells move in unpredictable, jittery paths. Standard software often cannot tell similar-looking cells apart when they are packed together. 麻豆原创’s open-source CancerCellTracker and machine-learning tools like TLCellClassifier help scientists follow thousands of individual cells at once.
Many tumors display molecules like PD-L1 that tell immune cells to stop attacking. The area around a tumor can also be hostile, lacking oxygen or carrying suppressive signals such as FGFR4. Some treatments fail because highly active immune cells build up brakes like TIGIT, which can make them attack each other in a process called fratricide.
Degrees for Jobs in Cancer Immunology
Curious about the science behind cancer immunology? These 麻豆原创 programs explore the cell biology, biomedical research and biotechnology behind how the immune system fights disease.